De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
CUC Inkomsten in het verleden
Verleden criteriumcontroles 5/6
CUC has been growing earnings at an average annual rate of 14.6%, while the Healthcare industry saw earnings growing at 6.9% annually. Revenues have been growing at an average rate of 9.8% per year. CUC's return on equity is 10.5%, and it has net margins of 8.6%.
Belangrijke informatie
14.6%
Groei van de winst
4.8%
Groei van de winst per aandeel
| Healthcare Groei van de industrie | 7.9% |
| Inkomstengroei | 9.8% |
| Rendement op eigen vermogen | 10.5% |
| Nettomarge | 8.6% |
| Volgende winstupdate | 28 Oct 2024 |
Recente prestatie-updates uit het verleden
Recent updates
CUC (TSE:9158) May Have Issues Allocating Its Capital
Sep 04
CUC Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Jul 26Is CUC (TSE:9158) Using Too Much Debt?
Jul 17Take Care Before Jumping Onto CUC Inc. (TSE:9158) Even Though It's 27% Cheaper
Jun 15Results: CUC Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts
Apr 28More Unpleasant Surprises Could Be In Store For CUC Inc.'s (TSE:9158) Shares After Tumbling 35%
Apr 27Opbrengsten en kosten
Hoe CUC geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Jun 24 | 35,959 | 3,079 | 13,129 | 0 |
| 31 Mar 24 | 33,025 | 2,595 | 9,833 | 0 |
| 31 Dec 23 | 31,133 | 1,779 | 11,432 | 0 |
| 30 Sep 23 | 31,862 | 1,952 | 10,802 | 0 |
| 30 Jun 23 | 32,737 | 1,992 | 10,459 | 0 |
| 31 Mar 23 | 35,210 | 2,423 | 10,015 | 0 |
| 31 Mar 22 | 35,314 | 2,707 | 8,788 | 0 |
| 31 Mar 21 | 16,606 | 1,100 | 5,711 | 0 |
Kwaliteitswinsten: 9158 has high quality earnings.
Groeiende winstmarge: 9158's current net profit margins (8.6%) are higher than last year (6.1%).
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: 9158's earnings have grown by 14.6% per year over the past 5 years.
Versnelling van de groei: 9158's earnings growth over the past year (54.6%) exceeds its 5-year average (14.6% per year).
Winst versus industrie: 9158 earnings growth over the past year (54.6%) exceeded the Healthcare industry 8.2%.
Rendement op eigen vermogen
Hoge ROE: 9158's Return on Equity (10.5%) is considered low.